Definitive Healthcare reports inducement grants under Nasdaq listing rule

Definitive Healthcare (DH) announced that in connection with the hiring of a senior leader, that the Human Capital Management and Compensation Committee of Definitive Healthcare’s Board of Directors granted an inducement award. The Committee granted Tina Hannagan, Definitive Healthcare’s Chief Commercial Officer, an inducement award consisting of 830,565 time-based restricted stock units effective June 1, 2025. This award was individually negotiated and was granted as an inducement material to Ms. Hannagan’s commencement of employment with Definitive Healthcare in accordance with Nasdaq Listing Rule 5635(c)(4). The award is subject to the terms and conditions of Definitive Healthcare’s 2023 Inducement Plan and the terms and conditions of an applicable award agreement covering the grant. Ms. Hannagan’s RSUs will vest as follows, subject to Ms. Hannagan’s continued employment through each such date: 25% will vest on June 1, 2026; the remainder will vest in quarterly installments equal to 6.25% of the total RSUs over the subsequent 3 years, until fully vested.